{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12880315", "DateCompleted": {"Year": "2004", "Month": "02", "Day": "23"}, "DateRevised": {"Year": "2006", "Month": "11", "Day": "15"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "66", "Issue": "7", "PubDate": {"Year": "2003", "Month": "Jul"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antiparasitic alkaloids from Psychotria klugii.", "Pagination": {"StartPage": "962", "EndPage": "967", "MedlinePgn": "962-7"}, "Abstract": {"AbstractText": ["Psychotria klugii yielded two new benzoquinolizidine alkaloids, klugine (1) and 7'-O-demethylisocephaeline (2), together with the previously known cephaeline (3), isocephaeline (4), and 7-O-methylipecoside (5). The structures and stereochemistry of 1 and 2 were determined by 1D and 2D NMR data and circular dichroism experiments. Cephaeline (3) demonstrated potent in vitro antileishmanial activity against Leishmania donavani (IC(50) 0.03 microg/mL) and was >20- and >5-fold more potent than pentamidine and amphotericin B, respectively, while klugine (1) (IC(50) 0.40 microg/mL) and isocephaeline (4) (IC(50) 0.45 microg/mL) were <13- and <15-fold less potent than 3. In addition, emetine (6) (IC(50) 0.03 microg/mL) was found to be as equally potent as 3, but was >12-fold more toxic than 3 against VERO cells (IC(50) 0.42 vs 5.3 microg/mL). Alkaloids 1 and 3 exhibited potent antimalarial activity against Plasmodium falciparum clones W2 and D6 (IC(50) 27.7-46.3 ng/mL). Compound 3 was cytotoxic to SK-MEL, KB, BT-549, and SK-OV-3 human cancer cells, while 1 was inactive."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research and Department of Pharmacology, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, Mississippi 38677, USA. milias@olemiss.edu"}], "Identifier": [], "LastName": "Muhammad", "ForeName": "Ilias", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dunbar", "ForeName": "D Chuck", "Initials": "DC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khan", "ForeName": "Shabana I", "Initials": "SI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tekwani", "ForeName": "Babu L", "Initials": "BL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bedir", "ForeName": "Erdal", "Initials": "E"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Takamatsu", "ForeName": "Satoshi", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ferreira", "ForeName": "Daneel", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Walker", "ForeName": "Larry A", "Initials": "LA"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "7'-O-demethylisocephaeline"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolines"}, {"RegistryNumber": "0", "NameOfSubstance": "klugine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects"], "DescriptorName": "Leishmania donovani"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Nuclear Magnetic Resonance, Biomolecular"}, {"QualifierName": [], "DescriptorName": "Peru"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": ["chemistry"], "DescriptorName": "Psychotria"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Quinazolines"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "7", "Day": "26", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "2", "Day": "24", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "7", "Day": "26", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12880315", "10.1021/np030086k"]}}], "PubmedBookArticle": []}